News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|December 22, 2022

Stages and Progression of T1D

Author(s)Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, Kimberly Simmons, MD

Kimberly Simmons, MD, reviews stages 1, 2, and 3 of pediatric T1D progression.

Episodes in this series

EP. 1 Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

EP. 1 Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

EP. 2 Stages and Progression of T1D

EP. 2 Stages and Progression of T1D

EP. 3 Importance of Screening for T1D

EP. 3 Importance of Screening for T1D

EP. 4 Lifestyle Management in T1D

EP. 4 Lifestyle Management in T1D

EP. 5 Approaching T1D Screening Retesting

EP. 5 Approaching T1D Screening Retesting

EP. 6 Emerging Treatments in T1D

EP. 6 Emerging Treatments in T1D

EP. 7 Blood Glucose Monitoring in T1D

EP. 7 Blood Glucose Monitoring in T1D

EP. 8 Key Takeaways for Screening and Diagnosis of T1D

EP. 8 Key Takeaways for Screening and Diagnosis of T1D

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetes

Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetes

ByJamie Wood, MD

June 4th 2026

Kevin Kaiserman, MD, discusses the impact of the first inhaled insulin approval for pediatrics

Kevin Kaiserman, MD, discusses the impact of the first inhaled insulin approval for pediatrics

ByKevin Kaiserman, MD

May 29th 2026

FDA approves inhaled insulin Afrezza for children and adolescents with diabetes

FDA approves inhaled insulin Afrezza for children and adolescents with diabetes

ByMorgan Ebert, Executive Editor

May 29th 2026

Early antibiotic exposure shows limited link to pediatric T1D risk | Image Credit: © Sirirat Makprasert - © Sirirat Makprasert - stock.adobe.com.

Early antibiotic exposure shows limited link to pediatric T1D risk

ByCeleste Krewson, Assistant Editor

May 22nd 2026

Mental health disorders affect more than 1 in 4 pediatric patients with diabetes

Mental health disorders affect more than 1 in 4 pediatric patients with diabetes

ByHannah Murphy, PhD

May 15th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetes

How to recognize and when to refer for children with hidradenitis suppurativa

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

Simple screening questions may help pediatricians identify hidradenitis suppurativa earlier

Treat, watch, or refer: A pediatrician’s guide to common infectious skin diseases